For absolute transparency and scientific rigor, the EMVA platform clearly defines its screening scope. The terminal is not a universal diagnostic tool, but a high-resolution optical window calibrated on precise biomarkers of microcirculation, blood, and cellular matrix.
What the EMVA platform CAN detect early (Area of Excellence)
By analyzing the reflectance spectrum (380 – 730 nm), the AI algorithm correlates peripheral chemical and vascular changes, providing early clues in major medical fields:
1. Systemic Syndromes and Indirect Oncological Footprints
- Systemic Oncological Footprints (Indirect Indicators): The EMVA terminal does not localize or diagnose internal tumors, nor does it replace dermatoscopy in evaluating malignant skin lesions. However, severe malignant tumors induce widespread systemic alterations throughout the entire organism. The algorithm is capable of detecting the phenomenon of accelerated peripheral angiogenesis (reflectance alterations in the 530–580 nm range induced by vascular endothelial growth factors secreted by tumor formations) and the “sallow/earthy signature” of critical oxidative stress (in the 650–730 nm range). Taken together, these cumulative optical biomarkers signal a major state of chronic biological depletion, indicating the critical need for specialized oncological or internal medical screening.
2. Cardiovascular and Circulatory Conditions
- Blood Dynamics and Vascular Stiffness: The analysis of the blood’s “W” curve provides details on the quality of oxygen transport.
- Clinical Applications: Early identification of tissue hypoxia states (poor oxygenation), severe peripheral circulation deficiencies, profound anemias, as well as indirect indicators of vascular wall stiffening (correlated with the risk of hypertension or latent atherosclerosis).
3. Digestive Conditions and Metabolic Disorders
- Hepatobiliary and Digestive System: The 450-480 nm spectral zone reacts instantly to the presence of bilirubin. The AI detects toxic accumulations in tissues, signaling risks of hepatic steatosis (fatty liver), chronic liver fatigue, or biliary dysfunctions long before they cause digestive symptoms or visible jaundice in the eyes.
- Pancreatic System / Diabetic Risk: The evaluation of the Glycation Index (AGEs: 420-440 nm) measures “sugared” proteins in the body. Increased absorption is a clear indication of problems in glucose processing, providing an early warning signal for prediabetes or metabolic syndrome.
4. Systemic Syndromes and Low-Grade Inflammation
- Biological Exhaustion: Detection of the “sallow signature” in the deep red zone (650-730 nm), directly correlated with severe oxidative stress, burnout syndrome, and latent chronic inflammations that underlie most modern diseases.
Secondary Signs / Alert Indicators
- Hypoxia and Respiratory Insufficiency (e.g., Pneumonia, severe Asthma): The terminal does not diagnose the pulmonary infection itself, but it immediately identifies critical degradation of blood oxygenation (flattening of the oxyhemoglobin curve) caused by impaired lung function, generating an emergency triage alert.
What the EMVA terminal CANNOT detect (Technology Limitations)
- Deep Structural Organic Pathologies: It does not replace ultrasound or MRI (it cannot see lung nodules, isolated brain tumors, or kidney stones).
- Acute Infectious or Viral Diseases: It cannot detect the presence of bacteria, viruses (flu, COVID-19), or parasites.
- Neurological Conditions directly: Diseases such as Alzheimer’s or Parkinson’s do not have a direct, measurable cutaneous spectral signature.
Medical Conclusion:
“By combining these indicators, EMVA does not look for a single disease, but maps the general vitality of the organism. An alarm signal in any of these areas redirects the patient to a medical specialist exactly in the asymptomatic phase – the only one in which prevention has a 100% success rate.”
Target user segment: The EMVA terminal is intended for individuals over the age of 14. Although the optical technology is completely safe and non-invasive, the spectral analysis AI algorithms are calibrated exclusively on the cellular structure, vascular density, and tissue biochemistry of mature subjects.
Important: Disclaimer and Legal Framework
By combining these indicators, EMVA does not look for a single disease, but maps the general vitality of the organism. An alarm signal in any of these areas redirects the patient to a medical specialist exactly in the asymptomatic phase – the only one in which prevention has maximum success.
Note regarding medical responsibility: EMVA Skin is a screening and preventive monitoring instrument. It does not issue medical diagnoses and does not replace standard clinical investigations (ultrasound, laboratory tests, MRI, etc.). The use of the system is intended to signal the need for further investigations in case of deviations from optimal health parameters.
We always recommend validating the results by consulting a medical specialist.